Kontigo Care AB (3KT) Stock Price & Analysis
3KT Stock Chart & Stats
- Day’s Range
- EUR 0.06 - EUR 0.08
- 52-Week Range
- EUR 0.01 - EUR 0.16
- Previous Close
- EUR 0.08
- Volume
- 0
- Average Volume (3M)
- 0
- Market Cap
- EUR 4.02M
- Enterprise Value
- EUR 40.87M
- Total Cash (Recent Filing)
- EUR 13.24M
- Total Debt (Recent Filing)
- EUR 0
- Price to Earnings (P/E)
- ―
- Beta
- 0.92
- Next Earnings
- Nov 30, 2026 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Strong Revenue Re-acceleration
The sharp TTM revenue rebound indicates improving demand and renewed commercial momentum. If maintained, stronger sales can improve operating leverage, support broader customer adoption, and create a larger recurring revenue base for the remote monitoring business over the next several quarters.
Debt-Free Balance Sheet
Zero debt materially reduces financial risk and limits the burden of interest expense or refinancing. A solid equity position gives Kontigo Care greater resilience while profitability remains uneven, preserving flexibility to support operations and invest in its healthcare monitoring platform.
High Gross Margin And Improving EBITDA Margin
A very high gross margin indicates that incremental revenue may carry attractive economic contribution after direct costs. The improvement in EBITDA margin also suggests operating performance is moving in a better direction, which could help convert renewed revenue growth into more durable profitability.
Bears Say
Persistent Losses And Earnings Volatility
Returning to operating and net losses after several profitable years demonstrates that earnings are not yet consistent. This volatility makes the business less predictable, limits internally generated capital, and indicates that stronger revenue has not yet translated into dependable bottom-line performance.
Negative Free Cash Flow
Sustained negative free cash flow means the company is not yet funding investment and working-capital needs from internal cash generation. Even with positive operating cash flow, continued cash outflows can constrain growth initiatives and increase reliance on external financing over time.
Negative Return On Equity
Negative TTM return on equity shows that the existing capital base is currently producing losses rather than acceptable returns. Until profitability improves, shareholder capital is being used inefficiently, which can weaken long-term compounding and restrict the company’s ability to reinvest productively.
3KT FAQ
What was Kontigo Care AB’s price range in the past 12 months?
What is Kontigo Care AB’s market cap?
When is Kontigo Care AB’s upcoming earnings report date?
How were Kontigo Care AB’s earnings last quarter?
Is Kontigo Care AB overvalued?
Does Kontigo Care AB pay dividends?
What is Kontigo Care AB’s EPS estimate?
How many shares outstanding does Kontigo Care AB have?
What happened to Kontigo Care AB’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Kontigo Care AB?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Kontigo Care AB
Kontigo Care AB (publ) specializes in delivering healthcare solutions aimed at addressing addiction issues within Sweden. Their product portfolio includes Previct Alcohol, a digital medical device designed to manage alcohol dependence, and Previct Gambling, a digital application for tackling gambling addiction. Established in 2013, the firm maintains its primary operations in Uppsala, Sweden.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Alexander Stendahl
- Employees
- 11
- Website
- www.kontigocare.com
- Address
- Bangårdsgatan 4A, Uppsala, 753 20, SE
Kontigo Care AB (3KT) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 5 | 11 |
| Technical Analysis | 4 | 5 | 1 |
| Moving Averages | 2 | 0 | 10 |
